Get the Stockscreener App
16.51
0.43%
0.07
After Hours:
16.42
-0.09
-0.55%
Omada Health Inc stock is traded at $16.51, with a volume of 559.60K.
It is up +0.43% in the last 24 hours and up +13.00% over the past month.
Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor's visits. The integrated platform of the company supports members with cardiometabolic conditions like prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health needs. The company's specialized care tracks also assist members using GLP-1 medications. The company delivers measurable health outcomes and value for employers, health plans, health systems, and pharmacy benefit managers.
See More
Previous Close:
$16.44
Open:
$16.48
24h Volume:
559.60K
Relative Volume:
0.44
Market Cap:
$981.49M
Revenue:
$260.21M
Net Income/Loss:
$-12.78M
P/E Ratio:
-72.19
EPS:
-0.2287
Net Cash Flow:
$12.42M
1W Performance:
-0.30%
1M Performance:
+13.00%
6M Performance:
-11.24%
1Y Performance:
+0.00%
1-Day Range:
$16.23
$16.90
1-Week Range:
$15.97
$17.10
52-Week Range:
$10.28
$26.91
Omada Health Inc Stock (OMDA) Company Profile
Name
Omada Health Inc
Sector
Industry
Phone
888-987-8337
Address
611 GATEWAY BLVD., SOUTH SAN FRANCISCO
Compare OMDA vs VEEV, BTSG, TEM, HQY, HNGE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OMDA
Omada Health Inc
|
16.51 | 977.33M | 260.21M | -12.78M | 12.42M | -0.2287 |
VEEV
Veeva Systems Inc
|
160.17 | 25.83B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
58.50 | 11.25B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
46.18 | 8.35B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
88.11 | 7.25B | 1.31B | 215.20M | 408.32M | 2.4627 |
HNGE
Hinge Health Inc
|
55.25 | 4.27B | 646.34M | -512.40M | 202.76M | -6.6871 |
Omada Health Inc Stock (OMDA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-14-26 | Initiated | Citizens | Mkt Outperform |
| Jan-09-26 | Initiated | Wells Fargo | Equal Weight |
| Nov-13-25 | Initiated | BMO Capital Markets | Outperform |
| Sep-05-25 | Initiated | Robert W. Baird | Neutral |
| Jul-01-25 | Initiated | Barclays | Overweight |
| Jul-01-25 | Initiated | Canaccord Genuity | Buy |
| Jul-01-25 | Initiated | Evercore ISI | Outperform |
| Jul-01-25 | Initiated | Goldman | Buy |
| Jul-01-25 | Initiated | JP Morgan | Overweight |
| Jul-01-25 | Initiated | Morgan Stanley | Overweight |
| Jul-01-25 | Initiated | Needham | Buy |
View All
Omada Health Inc Stock (OMDA) Latest News
Oceaneering Stock Is Up 105% in a Year, and One Fund Just Disclosed a $7 Million Bet on More Growth - The Motley Fool
Omada Health’s people chief on HR strategy spring cleaning - HR Brew
Omada Health: A Great Company Without Pricing Power (NASDAQ:OMDA) - Seeking Alpha
Morgan Stanley Maintains Omada Health(OMDA.US) With Buy Rating, Maintains Target Price $30 - Moomoo
Compared to estimates, Omada Health, Inc. (OMDA) Q1 earnings: A look at key metrics - MSN
Andreessen Horowitz affiliates report OMDA stakes (OMDA) — March 31, 2026 - Stock Titan
Divisadero Group discloses 9.9% stake in Omada Health (OMDA) - Stock Titan
Omada Health (OMDA) price target decreased by 16.75% to 22.54 - MSN
How this Eli Lilly-tied IPO stock fared in its first quarter - MSN
Number of shareholders of Omada Health, Inc. – NASDAQ:OMDA - TradingView
Scaling Risks Cloud Omada Health’s Growth Prospects Amid Limited Operating History - TipRanks
The Private Shares Fund's Omada Health Inc(OMDA) Holding History - GuruFocus
BMO Capital Sticks to Its Buy Rating for Omada Health, Inc. (OMDA) - The Globe and Mail
Omada Health Earnings Call Signals Profitable Scale - TipRanks
CCORF Maintains Omada Health(OMDA.US) With Buy Rating, Raises Target Price to $24 - Moomoo
Omada Health price target raised to $18 from $17 at Wells Fargo - TipRanks
42% revenue surge as Omada Health (NASDAQ: OMDA) narrows Q1 2026 loss - Stock Titan
Omada Health (OMDA) Q1 2026 Earnings Transcript - AOL.com
Omada Health reports 42% revenue boost, GLP-1 partnership - TechTarget
Omada Health Q1 2026 slides: 42% revenue growth, positive EBITDA By Investing.com - Investing.com Australia
Omada Health Q1 Earnings Call Highlights - Barchart.com
Citizens raises Omada Health stock price target on growth outlook By Investing.com - Investing.com South Africa
Citizens raises Omada Health stock price target on growth outlook - Investing.com UK
Omada Health Q1 2026 slides: 42% revenue growth, positive EBITDA - Investing.com
Omada Health Q1 2026 Earnings Call Transcript - MarketBeat
Earnings call transcript: Omada Health Q1 2026 sees EPS beat, stock rises - Investing.com Nigeria
Omada outlines 2026 revenue of $322M-$330M as adjusted EBITDA guidance rises to $14M-$20M - MSN
Compared to Estimates, Omada Health, Inc. (OMDA) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
Omada Health joins Eli Lilly employer weight loss program - Investing.com
Omada Health joins Eli Lilly employer weight loss program By Investing.com - Investing.com South Africa
Omada Health (NASDAQ:OMDA) Soars on Q1 Beat, Raised Guidance and Key Partnerships - ChartMill
OMADA HEALTH ($OMDA) Releases Q1 2026 Earnings, Stock Rises - Quiver Quantitative
Earnings Flash (OMDA) Omada Health, Inc. Reports Q1 Revenue $78.0M, vs. FactSet Est of $74.1M - marketscreener.com
44% of surveyed GLP-1 patients pay over $250 a month as Omada adds Lilly channel - Stock Titan
Omada Health Reports First Quarter 2026 Results - The Manila Times
Omada Health Joins Lilly Employer Connect, Expanding Its Access Pathways for GLP-1 Care as Patients Seek More Lifestyle Support - Yahoo Finance
One million members: Omada now works with all 3 top drug-benefit managers - Stock Titan
Omada Health 1Q Loss/Shr 5c >OMDA - Moomoo
Omada Health (NASDAQ: OMDA) posts 42% Q1 revenue jump, raises 2026 outlook - Stock Titan
Omada Health, Inc. Provides Earnings Guidance for the Year Ending December 31, 2026 - marketscreener.com
FMR LLC discloses 3.29M-share stake in Omada Health (NASDAQ: OMDA) - Stock Titan
CCORF Maintains Omada Health(OMDA.US) With Buy Rating, Maintains Target Price $22 - Moomoo
Analyst Reiterates Buy on Omada Health, Maintains $22 Price Target on Robust GLP-1-Driven Demand and Strategic Partnerships - TipRanks
77,451 Shares in Omada Health, Inc. $OMDA Acquired by Universal Beteiligungs und Servicegesellschaft mbH - MarketBeat
Earnings Preview: Omada Health to Report Financial Results Post-market on May 07 - Moomoo
Digital Therapeutics Market Size Accelerating at 24.8% CAGR | - openPR.com
[ARS] Omada Health, Inc. SEC Filing - Stock Titan
Omada Health Inc Stock (OMDA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.66%
4.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):